Nitroglycerin Sustained Release Tablet. Formulation Design and Evaluation

Table of Contents

CHAPTER 1: INTRODUCTION

1.1 Introduction

1.2 Historical viewpoints of controlled release drug delivery

1.3 Sustained release drug delivery system

1.3.1 Concept of sustained release drug delivery system

1.3.2 Rationale of sustained release drug delivery system

1.3.3 Oral sustained release drug delivery system

1.3.4 Advantages of sustained release dosage forms

1.3.5 Disadvantages of sustained release dosage forms

1.3.6 Drugs unsuitable for sustained release dosage forms

1.3.7 Factors affecting sustained release dosage forms

1.3.7.1 Physicochemical properties of the drug affecting sustained release dosage forms

1.3.7.2 Biological properties of the drug affecting sustained release dosage forms

1.3.8 Formulation methods used to prepare sustained release dosage forms

1.3.8.1 Particle size modification

1.3.8.2 Matrix system

1.3.8.3 Coating system

1.3.8.4 Beads and sphere

1.3.8.5 Enteric coated beads in capsule

1.3.8.6 Mixed release granules

1.3.8.7 Repeated action tablets

1.3.8.8 Erosion core with initial dose

1.3.8.9 Erosion core only

1.3.8.10 Ion exchange resin

1.3.8.11 Complexation

1.3.8.12 Microencapsulation

1.3.8.13 The osmotic tablet

1.3.8.14 Gel forming hydrocolloids

1.3.8.15 Environmentally responsive system

1.3.9 Methods and mechanisms of sustaining drug action

1.3.9.1 Diffusional systems

1.3.9.2 Dissolution controlled system

1.3.9.3 Water penetration controlled system

1.3.9.4 Chemically controlled systems

1.3.9.5 Hydrogels

1.3.9.6 Ion exchange resins

1.3.10 Technical sophistication based classification of sustained release drug delivery

1.4 Matrix devices

1.4.1 Polymers used in matrix devices

1.4.2 Properties of an ideal polymer

1.4.3 Classification of polymers

1.4.3.1 Matrix devices with insoluble inert polymer

1.4.3.2 Matrix devices with insoluble erodible polymer

1.4.3.3 Matrix devices with hydrophilic polymer

1.4.3.4 Matrix devices with hydrogel polymer

1.4.4 Use of excipients in matrix devices

1.4.5 Release mechanisms from matrices

1.4.6 Mathematical models of release mechanics from matrices

1.4.6.1 Release from soluble retardants

1.4.6.2 Release from insoluble retardants

1.4.6.3 Drug release of low solubility in eluting media

1.4.6.4 Exponential model

1.4.6.5 Geometric dependence of diffusion exponent (n) and variation of n values with mechanism of diffusion

1.5 Thesis topic

1.5.1 Rationale

1.5.2 Active component

1.5.3 Physico-chemical properties of Nitroglycerin

1.5.4 Mechanism of action

1.5.5 Therapeutic use

1.5.6 Therapeutic dose

1.5.7 Contraindications

1.5.8 Pharmacokinetics

1.5.9 Pharmacology and toxicology

1.5.9.1 Mode of action

1.5.9.2 Interactions

1.5.9.3 Nitrate tolerance

1.5.10 Clinical effects

1.5.10.1 Acute poisoning

1.5.10.2 Chronic poisoning

1.5.11 Management of clinical effects

1.5.12 Decontamination

CHAPTER 2 : MATERIALS AND METHODS

2. Materials and methods

2.1 Materials

2.2. Drug profile

2.3. Excipients profile

2.3.1 Methocel

2.3.1.1 Nomenclature

2.3.1.2 Chemistry

2.3.1.3 Degree of substitution

2.3.1.4 Properties of Methocel K15M CR and Methocel K100LV CR

2.3.2 Profile of colloidal Silicon Dioxide (Aerosil 200)

2.3.3 Profile of Magnesium Stearate

2.4 Methods of study

2.4.1 Preparation of matrix tablet

2.4.2 Formulation of Nitroglycerin matrix tablet (F-1 – F-9)

2.5 Characterization of Nitroglycerin matrix tablets

2.5.1 Evaluation of physical properties of formulation granules

2.5.1.1 Bulk density

2.5.1.2 Compressibility index

2.5.1.3 Total porosity

2.5.1.4 Pharmacology and toxicology

2.5.1.5 Moisture content

2.5.1.6 Flow properties

2.5.1.7 Assay

2.5.2 Evaluation of physical properties of matrix tablet

2.5.2.1 Weight variation test

2.5.2.2 Hardness

2.5.2.3 Friability

2.5.2.4 Surface area

2.5.2.5 Moisture content

2.5.3 Chemical assay of Nitroglycerin in matrix tablets

2.5.3.1 Uniformity of content of active Nitroglycerin

2.5.3.2 Assay of Nitroglycerin after preparation of tablets

2.5.3.3 Assay of Nitroglycerin after 1 Month at 40°C + 75%RH

2.5.4 In-vitro release studies of Nitroglycerin matrix tablet

2.5.4.1 In-vitro dissolution medium

2.5.4.2 In-vitro dissolution studies of the tablet matrix

2.5.5 In-vitro release kinetic models

2.5.5.1 Zero order equation

2.5.5.2 First order equation

2.5.5.3 Higuchi square root law

2.5.5.4 Korsmeyer-Peppas model

2.5.5.5 Hixson-Crowell cube root law

2.5.6 Successive fractional dissolution time

CHAPTER 3: RESULTS AND DISCUSSION

3. Results and discussion

3.1 Evaluation of physical properties of Nitroglycerin granules

3.2 Evaluation of physical properties of Nitroglycerin tablets

3.3 Assay of Nitroglycerin matrix tablet

3.3.1 Uniformity of content of active Nitroglycerin

3.3.2 Assay of Nitroglycerin in the matrix tablet

3.3.3 Assay of Nitroglycerin after 1 Month at 40°C+75%RH in the matrix tablet

3.4 In-vitro dissolution and kinetic studies of Nitroglycerin matrix tablet in formulations (F–1 to F–9)

3.4.1 Effect of Methocel K15M CR (25%,20%,15%) and Methocel K100LV CR (15%,10%,5%) on release pattern of Nitroglycerin Matrix tablet

3.4.1.1 Zero order plot

3.4.1.2 First order plot

3.4.1.3 Higuchi plot

3.4.1.4 Korsmeyer-Peppas plot

3.4.1.5 Hixson-Crowell plot

3.4.2 Interpretation of release rate constant and R-square values for different release kinetics of (F–1 to F–9)

3.4.3 The best fitted model and mechanism of drug release from the matrix tablet of Nitroglycerin

3.4.4 Successive fractional dissolution time

3.5 Discussion about formulations (F–1 to F–9)

CHAPTER 4: CONCLUSION

4 Conclusion

CHAPTER 5: BIBLIOGRAPHY

5 Bibliography

Objectives and Topics

This dissertation aims to develop and characterize sustained-release matrix tablets containing 2.6 mg of Nitroglycerin. The research utilizes two distinct viscosity grades of hydroxypropyl methylcellulose (HPMC) polymers—Methocel K15M CR and Methocel K100LV CR—as rate-retarding agents to achieve an 8-hour sustained-release profile. The study evaluates the formulation's physical properties, stability under accelerated stress conditions, and drug release kinetics through various mathematical models to determine the optimal polymer ratios for consistent therapeutic delivery.

• Formulation design of Nitroglycerin matrix tablets using HPMC polymers.
• Evaluation of pre-compression granular properties and post-compression tablet characteristics.
• In vitro dissolution testing to assess release performance over 8 hours.
• Mathematical kinetic modeling (Zero order, First order, Higuchi, Korsmeyer-Peppas, Hixson-Crowell) to identify release mechanisms.
• Stability testing under accelerated conditions (40°C and 75% relative humidity).

Excerpt from the Book

Summary of Chapters

CHAPTER 1: INTRODUCTION: This chapter covers the fundamental concepts of controlled release systems, historical developments, various formulation techniques, factors affecting drug release, and the specific application of matrix devices for sustained action.

CHAPTER 2 : MATERIALS AND METHODS: This chapter details the ingredients, instruments, and methodological procedures used for preparing the matrix tablets and conducting evaluation tests such as granule flow, tablet characterization, and in vitro dissolution studies.

CHAPTER 3: RESULTS AND DISCUSSION: This chapter presents the experimental findings regarding the physical properties of the developed formulations and the analytical results of kinetic studies to evaluate the best-fitted release models.

CHAPTER 4: CONCLUSION: This chapter summarizes the project's achievements, noting that optimized polymer ratios successfully met the desired release criteria for 8-hour sustained-release Nitroglycerin tablets.

CHAPTER 5: BIBLIOGRAPHY: This section lists the scientific literature, pharmacological handbooks, and industrial technical references utilized throughout the research.

Keywords

Nitroglycerin, Sustained Release, Matrix Tablet, HPMC, Methocel, Dissolution, Kinetic Modeling, Higuchi Equation, Korsmeyer-Peppas, Drug Formulation, Controlled Release, Polymer Matrix, Bioavailability, Pharmaceutical Technology, Stability Study

Frequently Asked Questions

What is the core focus of this research?

This work primarily focuses on the design and evaluation of hydrophilic matrix-based sustained-release tablets of Nitroglycerin intended to provide therapeutic effects over an 8-hour duration.

What are the primary themes addressed?

The central themes include the formulation strategies for matrix tablets, the impact of different HPMC polymer ratios, physical characterization of granules and tablets, and detailed kinetic analysis of drug release profiles.

What is the research goal?

The primary goal is to formulate a stable, sustained-release Nitroglycerin tablet that improves patient compliance and reduces side effects compared to conventional dosage forms by maintaining effective drug levels for 8 hours.

Which methodology is employed?

The research uses the direct compression method to manufacture tablets. Evaluation methods include HPLC analysis for assay and content uniformity, as well as USP-2009 Apparatus-I for dissolution studies.

What is covered in the main body?

The main body examines the theoretical foundations of sustained delivery, the specific materials used, the detailed formulation process, the characterization of the physical properties, and a rigorous evaluation of the release kinetics through mathematical models.

Which keywords define this study?

The study is best characterized by terms such as Nitroglycerin, Sustained Release, Matrix Tablet, HPMC, Dissolution, Kinetic Modeling, and Polymer Matrix.

Why are Methocel K15M CR and K100LV CR used?

These HPMC grades are used as rate-retarding agents. Their varied viscosity allows for the fine-tuning of the drug release rate from the hydrophilic matrix, ensuring the release duration is extended effectively.

What do the kinetic models reveal about the release mechanism?

The study found that the release mechanism for all proposed formulations followed an anomalous or non-Fickian transport pattern, suggesting a combination of both diffusion-controlled and erosion-controlled drug release processes.